The overarching goal of the Raymond and Beverly Sackler Convergence Laboratory (RSBCL) is to address the most pressing diseases and medical conditions facing society by encouraging collaborative research enterprises among investigators in various scientific fields. In 2013, the Raymond and Beverly Sackler Foundation pledged its ongoing support of convergent research through the establishment of an endowed fund at Tufts University School of Medicine. Given Tufts University’s history of—and continued commitment to—conducting impactful, interdisciplinary research that addresses complex global challenges through maximizing resources, Tufts is an ideal home for this forward-thinking convergence model.
Under the direction of the Fund Director, Charlotte Kuperwasser, Ph.D., Professor of Developmental, Molecular, and Chemical Biology at Tufts, the RSBCL aims to accomplish the following goals:
- Establish and foster collaborations with and between laboratories that span specific academic fields: biomedical (life/medicine), physical, mathematics and engineering sciences. Members of the Laboratory span institutes from Massachusetts (Tufts University School of Medicine, Tufts University, Whitehead Institute for Biomedical Research, Harvard Medical School, Massachusetts General Hospital, Beth Israel Deaconess Medical Center, Broad Institute of Harvard & MIT, Boston University), North Carolina (University of North Carolina, Chapel Hill), Arizona (The Biodesign Institute at Arizona State University), and California (City of Hope).
- Organize physical and virtual working groups on convergent themes
- Provide its members with access to Laboratory resources and technologies
- Provide its members with seed funding support for pilot convergence projects
- Support for a Postdoctoral Scholar
- Sponsor an annual symposium series